Equity Capital Markets

Company · CIK 1833769

Hyperfine, Inc.

CIK1833769 (SEC EDGAR)
Industry (SIC)3845 — Electromedical & Electrotherapeutic Apparatus
Incorporated inDE
Business addressCT
ListedHYPR (Nasdaq)
First annual or quarterly report2021-03-29

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-295807
ShelfEffective
 2026-05-122026-05-212
333-275449
ShelfEffective
 2023-11-092025-12-298
333-262300
Registered companyEffective
 2022-01-242023-01-304
333-252002
IPOFinal prospectus
 2021-01-112021-01-285

Filings

22
FiledFilingRegistrationAccession
2026-05-21EFFECTDeclared effective 333-2958079999999995-26-001730
2026-05-12S-3Shelf registered 333-2958070001193125-26-219646
2025-12-29424B5Shelf takedown 333-2754490001193125-25-335313
2025-10-16424B5Shelf takedown 333-2754490001193125-25-241446
2025-10-15424B5Shelf takedown 333-2754490001193125-25-240330
2025-05-13424B5Shelf takedown 333-2754490001193125-25-118856
2025-02-11424B5Shelf takedown 333-2754490001193125-25-024322
2024-03-22424B5Shelf takedown 333-2754490001193125-24-075343
2023-11-22EFFECTDeclared effective 333-2754499999999995-23-003420
2023-11-09S-3Shelf registered 333-2754490001193125-23-274569
2023-01-30EFFECTDeclared effective 333-2623009999999995-23-000217
2022-03-29EFFECTDeclared effective 333-2623009999999995-22-000754
2022-02-01EFFECTDeclared effective 333-2623009999999995-22-000297
2022-01-24S-1Registration filed 333-2623000001104659-22-006593
2021-11-26EFFECTDeclared effective 333-2591489999999995-21-004492
2021-07-19DRSDraft made public 377-052200001104659-21-093534
2021-01-28424B4Final prospectus 333-2520020001104659-21-008877
2021-01-26EFFECTDeclared effective 333-2520029999999995-21-000289
2021-01-19S-1/AAmendment 333-2520020001104659-21-005455
2021-01-11S-1/AAmendment 333-2520020001104659-21-003067
2021-01-11S-1Registration filed 333-2520020001104659-21-002582
2020-12-09DRSDraft made public 377-038640001104659-20-133656

All filings of this company · CSV